Pricing Log in Create free account
Monday 9 November 2026 Export AVLN’s income statement to Excel — free account

Avalyn Pharma Inc.

AVLN

Healthcare Biotechnology

29.15 2.48 +9.30%
Market cap
$1.3B
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
−102.6%
Net debt / EBITDA
—
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '25
Other line items

Show all line items

Columns are period end dates